We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 13, 2021

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 Variant of Concern 202012/01 (B.1.1.7)

The Lancet


Additional Info

The Lancet
Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 Variant of Concern 202012/01 (B.1.1.7): An Exploratory Analysis of a Randomised Controlled Trial
Lancet 2021 Apr 10;397(10282)1351-1362, KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, D Bonsall, P Cicconi, S Charlton, EA Clutterbuck, AM Collins, T Cox, TC Darton, C Dold, AD Douglas, CJA Duncan, KJ Ewer, AL Flaxman, SN Faust, DM Ferreira, S Feng, A Finn, PM Folegatti, M Fuskova, E Galiza, AL Goodman, CM Green, CA Green, M Greenland, B Hallis, PT Heath, J Hay, HC Hill, D Jenkin, S Kerridge, R Lazarus, V Libri, PJ Lillie, C Ludden, NG Marchevsky, AM Minassian, AC McGregor, YF Mujadidi, DJ Phillips, E Plested, KM Pollock, H Robinson, A Smith, R Song, MD Snape, RK Sutherland, EC Thomson, M Toshner, DPJ Turner, J Vekemans, TL Villafana, CJ Williams, AVS Hill, T Lambe, SC Gilbert, M Voysey, MN Ramasamy, AJ Pollard

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.